Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073658 · ClinicalTrials.gov registry record · Phase 2
Treating Behavioral Disturbances in Individuals With Dementia
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 137
- Enrollment target
NCT00073658 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 137 participants.
The verdict
NCT00073658, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 137 participants
- Enrollment target
Study Summary
This study will compare the safety and effectiveness two medications, citalopram (Celexa®) and risperidone (Risperdal®).
Interventions
- DRUG Risperidone
- DRUG Citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2000-01 |
| Est. Completion | 2005-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00073658
The ClinicalTrials.gov registry entry for NCT00073658 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Risperidone is the first listed.
NCT00073658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00073658 about?
NCT00073658 is a clinical study titled "Treating Behavioral Disturbances in Individuals With Dementia". This study will compare the safety and effectiveness two medications, citalopram (Celexa®) and risperidone (Risperdal®).
What is the current status of trial NCT00073658?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 137 participants. The study started on 2000-01. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00073658?
The interventions under investigation include: Risperidone (DRUG), Citalopram (DRUG).
Who is sponsoring clinical trial NCT00073658?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.